Tuberculosis, caused by Mycobacterium tuberculosis, and leprosy, caused by M. leprae, are diseases known since antiquity. In developing countries, tuberculosis is still the leading cause of mortality due to an infectious disease. Taxonomically, mycobacteria belong to the genus Mycobacterium, which is the single genus within the family of Mycobacteriaceae, in the order Actinomycetales. Actinomycetales include diverse micro-organisms, but mycobacteria and allied taxa are easily distinguished on the basis of the ability to synthesise mycolic acids. Mycobacterial species are traditionally differentiated on the basis of phenotypic characteristics, and the authors provide an updated list of the biochemical tests currently employed and the culture properties that help to discriminate among various species of mycobacteria. However, as the phenotypic characteristics do not allow precise identification of all species, recent molecular taxonomical approaches for mycobacterial classification and phylogeny are also described. Mycobacteria are also a leading cause of infection in various domesticated animals and wildlife. The authors briefly describe the mycobacteria involved in animal infections, the wildlife reservoirs and strategies to control bovine tuberculosis, and the use of molecular tools for diagnostics and epidemiology of mycobacterial infections in animals. The characteristic of intracellular parasitism is discussed, in addition to the fate of pathogenic mycobacteria that have the ability to grow inside phagosomes and phagolysosomes of infected host macrophages. The mycobacterial cell envelope, which is a complex tripartite structure containing a high proportion of lipids (approximately 30% to 40% of the total weight) could play a crucial role in the adaptation of mycobacteria to intracellular growth and survival, immune modulation and drug resistance.
Introduction
The genus Mycobacterium contains a number of strict and opportunistic pathogens that afflict humans and animals alike. Among the strict pathogens, the principal pathogens of humans include Mycobacterium tuberculosis, the causative agent of tuberculosis, and M. leprae, which causes leprosy. Opportunistic pathogens comprise a variety of mycobacterial species, including M. avium, M. simiae, M. kansasii and M. haemophilum, which are more common among immunocompromised patients. Other opportunistic mycobacterial infections are caused by M. ulcerous, which produces a destructive, primarily tropical skin disease which, if not treated rapidly, produces chronic ulcers with necrotic centres (also known as Buruli ulcer); M. marinum, responsible for fish-tank or swimming-pool granuloma which essentially concerns people exposed to fish or water; M. scrofulaceum, which has been associated with cervical lymphadenitis in children and may also cause pulmonary tuberculosis in adults; M. szulgai, which has been associated with pulmonary disease; M. xenopi, which was initially isolated from a skin lesion of a South African toad (Xenopus laevis), and is implicated in chronic pulmonary diseases as well as non-pulmonary infections in immunocompromised patients; and M. malmoense, which is associated with pulmonary disease and cervical adenitis. Recently described opportunistic pathogens include M. celatum and M. genavense, which are relatively more common among immunocompromised patients. Medically important rapidly growing mycobacteria are essentially limited to M. fortuitum, M. chelonae and M. abscessus and are associated with traumatic and surgical wound infections, skin and soft tissue infections and pulmonary disease. Lastly, the principal mycobacterial pathogens of animals include M. bovis, the causative agent of bovine tuberculosis, M. paratuberculosis, which causes Johne's disease or paratuberculosis in cattle, and M. avium, which is often associated with disease in pigs and poultry. However, of these many species of mycobacteria, the species that has been most troublesome, and about which current knowledge is the most extensive, is M. tuberculosis.
Suspected as the cause of death in some of the Egyptian mummies 3,000 years ago, tuberculosis is known to have been present since antiquity (108) . Recently, evidence for pulmonary tuberculosis, including the presence of acid-fast organisms, was also detected in a New World mummy from Peru, dated 700 AD. The importance of rest and the need for fresh air were suspected to be essential elements of treatment by Hippocrates, Celsus and Galen. Recognised as a contagious disease in Mediterranean culture during the 16th Century, and initially termed phthisis, pathological and anatomical characteristics of tuberculosis were reported in Opera Medica by Sylvius in 1679, and this was followed by the description of pathological features of miliary tuberculosis by Manget in 1702. The microbial nature of tuberculosis was suspected by the French military doctor Jean-Antoine Villemin as early as 1865, when a phthisis-like infection was successfully reproduced in rabbits and guinea-pigs which had been inoculated with a homogenate prepared from tuberculous lesions. Although air-borne infectiousness was also suspected by the English physician Benjamin Marten in 1720, according to Austin Flint, the non-communicability of tuberculosis was a general belief as late as 1881.
Also known as 'white plague', tuberculosis was a leading cause of death in Europe and the United States of America (USA) in the 19th Century (the estimated mortality rate from tuberculosis was as high as 400/100,000 in the USA in 1830). In this grim context, the Norwegian doctor G. Armauer Hansen identified, in 1873, the bacterium responsible for leprosy, and this was subsequently found to have a close resemblance to the tubercle bacillus, discovered nine years later by Koch, who was able to culture the tubercle bacillus on coagulated serum, and visualise the bacterium using a specialised staining method in 1882. Other important advances in tuberculosis research include the discovery of the acid-alcohol resistance of these organisms and characteristic Ziehl-Neelsen staining that is still routinely used (contributions of Ehrlich, Ziehl and Neelsen), the differentiation between avian and human tubercle bacillus (Rivolta 1889, Maffucci 1890), description of Koch's postulate and preparation of tuberculin in 1891 (Koch), and the description of the bovine tubercle bacillus by Smith in 1902.
Although the tuberculosis mortality rate had fallen to 200/100,000 by 1900, due to the improvements in social and sanitary conditions, a wider availability of adequate nutrition, and a wider use of sanatoria throughout Europe and the USA, the active therapy was still limited to surgical methods. However, the discovery of X-rays made it possible to detect and follow the progression of disease for the first time. During the years 1908 to 1920, Calmette and Guérin from the Pasteur Institute, France, used specific culture media to lower the virulence of the bovine tubercle bacillus (M. bovis). This work provided the background for the development of the bacillus Calmette-Guérin (BCG) vaccine that was used for the first time in 1921, and is still widely used. Another major breakthrough was achieved by Waksman in 1944, through the discovery of streptomycin, an antibiotic that is still used for tuberculosis chemotherapy. The subsequent discovery of other antimycobacterial drugs, such as para-amino salicylic acid in 1949, isoniazid in 1952, and rifampin in 1967, provided the basis for the standard antituberculous chemotherapy, in which three to four drugs are administered for a period of six to nine months.
As a result of efficient chemotherapy, BCG vaccination programmes and improved living conditions, a steady decline in tuberculosis notification rates occurred in industrialised countries (from 200/100,000 in 1900 to less than 10/100,000 in 1980 [79] ). However, a re-emergence of tuberculosis has been reported, with a higher percentage of drug resistant isolates since 1985, which has been associated with drug abuse, human immunodeficiency virus (HIV) infection, young patients, and a foreign origin of the patients (principally from the developing countries of Africa, South-East Asia, Latin America and the Caribbean, where tuberculosis remains an enormous health problem). The worsening socio-economic conditions in the industrialised world and the dismantling of the public health infrastructure to control tuberculosis have certainly played a crucial role in this re-emergence. In the developing world, tuberculosis remains an immense health and economic problem, causing approximately eight million new cases and three million deaths annually, making it the leading cause of mortality due to an infectious disease in these countries. Co-infection with HIV further complicates management of tuberculosis and considerably increases the mortality due to the disease in this group (130).
Nomenclature
The genus Mycobacterium is one of the oldest defined. The generic name Mycobacterium initially designated a group of organisms that grew as mould-like pellicles on liquid media (90) . At the beginning of last century, the characteristics used to define mycobacteria were the absence of motility, the morphology of the bacilli (slightly curved and rod-shaped), and the characteristic resistance to acid-alcohol following coloration with phenicated fuchsin (Ziehl-Neelsen stain). In the order Actinomycetales, mycobacteria belong to the genus Mycobacterium, which is the single genus within the family of Mycobacteriaceae (160) . Mycobacteria are defined as aerobic, acid-alcohol fast, rod-shaped actinomycetes with occasional branching; aerial hyphae are normally absent, and the bacteria are non-motile, non-sporulating organisms that contain arabinose, galactose, and meso-diaminopimelic in the cell wall; the guanine and cytosine (GC) deoxyribonucleic acid (DNA) base ratios are in the range of 62 mol % to 70 mol % (except for M. leprae, which has a GC base ratio of 58%); mycolic acids of high molecular weight (sixty to ninety carbons) are present, which lack components with more than two points of unsaturation in the molecule (63) . Although historically defined as unencapsulated organisms, mycobacteria are now known to possess a capsule-like structure (120) . Similarly, although initially considered as obligate aerobes, some species and strains are microaerophilic and grow as a narrow band under the surface of a semi-solid medium (63) . Actinomycetes include diverse micro organisms, in both ecological or morphological terms (63) . Differentiation between the mycobacteria and allied taxa (e.g. the members of the Corynebacterium, Mycobacterium and Nocardia [CMN] group which also includes the genera Rhodococcus, Gordona and Tsukamurella) can be easily performed, on the basis of the ability to synthesise mycolic acids that are high molecular weight (β-hydroxy fatty acids with a long α-side chain. Mycobacterial mycolic acids usually occur as complex mixtures of components that have oxygen functions such as carboxy, keto or methoxy groups, in addition to the 3-hydroxy acid system and combinations of cis or trans double bands or cyclopropane rings; methyl branches are also encountered. The members of the CMN group are the only micro-organisms that are able to synthesise mycolic acids (63) , however, on the basis of the number of carbon atoms and pyrolysis esters of the mycolic acids (as well as the GC content of the DNA), discrimination among the various CMN Table I Chemical characteristics of Mycobacterium and allied taxa group members is possible (Table I) . Consequently, the genus Mycobacterium is defined by the length of the carbon backbone, the number of unsaturated links, the presence of supplementary oxygenated functions, and the esters produced on pyrolysis.
Historically, the nomenclature of mycobacterial infections, irrespective of origin, was limited to tuberculous or non-tuberculous mycobacteria (also termed atypical mycobacteria or 'mycobacteria other than M. tuberculosis complex'). The former include M. tuberculosis, which is responsible for human tuberculosis, M. bovis, which is responsible for bovine tuberculosis, M. africanum, which causes human tuberculosis and is essentially limited to Africa, M. microti, which is a pathogen of small rodents, and the vaccinal strain M. bovis BCG. Although this classification is sufficient for practical purposes, the exact taxonomic status of a number of newly-described species, subspecies or subtypes is difficult to specify. This is best illustrated by the example of the pig or poultry pathogen belonging to the M. aviumintracellulare complex which, although known for years, suddenly became a focus of attention when acquired immune deficiency syndrome (AIDS) patients harbouring these bacteria were first diagnosed in the 1980s (130,132).
General structure of mycobacteria
The cell envelope plays a crucial role in the adaptation of mycobacteria to intracellular growth, for example by promoting the adhesion of mycobacteria to host macrophages and the acquisition of essential nutrients inside host cells, by inhibiting the microbicidal properties of the host and by determining eventual cell death (120) . The architecture and the constituents of the cell envelope not only intervene in intracellular survival and immune modulation, but are also instrumental in conferring drug resistance (120 understanding of these cell envelope constituents is also important as a means of developing potential drugs and/or treatment strategies to control resulting infection. Finally, these cell envelope constituents are among the initial factors contributing to host responsiveness. In the following section the term cell envelope is used to describe the bacterial cytoplasmic membrane, the cell wall and the mycobacterial capsule.
The structure-function relationships of the cell envelope have been extensively explored by chemical, ultrastructural, cytochemical and immunological methods. Although historically considered as unencapsulated organisms, recent electron microscopic data, using improved methods of embedding and immunocytochemical localisation of bacterial antigens, have provided evidence that pathogenic mycobacteria do contain a 'capsular structure' which not only contributes towards the permeability barrier of the mycobacterial cell envelope, but also protects the mycobacteria from the microbicidal activities of the host macrophage (120) . As underlined recently, a better understanding of the structure of the mycobacterial cell envelope and the biosynthesis and cell wall location of antigens, will help to define the specific roles of complex surface molecules and will also permit the development of specific inhibitors that are capable of interfering with drug resistance and virulence properties (13, 87) .
Mycobacterial capsule
Initial mycobacteria-macrophage interaction studies had revealed that intracellular mycobacteria were surrounded by a 'capsular structure' (CAP) or 'electron-transparent zone' of 70 nm to 100 nm (54), which protected the mycobacteria from host-mediated killing mechanisms (55). Subsequently, it was demonstrated that recycling of mycobacteria by the host permitted a better expression of this capsular material (58), implying that the synthesis of the capsular material is controlled, at least partially, by host-dependent regulatory mechanisms in pathogenic mycobacteria. The classical fixation methods used were presumed to cause the peripheral capsular material to collapse, hence protection of this material was necessary, either by saturating surface antigens of the bacteria with antisera raised against surface antigens such as the outer layer (OL) or CAP, or by using a novel gelatin-Lowicryl embedding (57). This protective capsular material was concluded to be an integral part of the mycobacterial cell envelope in the pathogenic species M. avium and M. tuberculosis, but not in the non-pathogenic species M. smegmatis. Using immunogold labelling under the electron microscope, the location of this capsular material was confirmed by locating specific surface antigens in ultra-thin sections of M. avium-intracellulare organisms (127) . These observations were in agreement with the findings that phagocytised M. avium are encapsulated, inhibit phagosome-lysosome fusions, and are able to grow intracellularly, whereas non-pathogenic M. aurum are uncapsulated, do not inhibit the phago-lysosome fusions and are rapidly degraded within phagolysosomes (54, 55). Some of these observations are illustrated in Figure 1 .
Previously, various subcellular fractions of M. avium organisms were isolated and used to raise antisera in rabbits. Upon immunolabelling of the bacteria using specific antisera, the location of OL epitopes was observed to be closer to the cell surface than the diffused labelling observed with CAP antisera, indicating that although the majority of the structural antigens in M. avium remained close to the wall, some protruded outwards (probably because of the size of these antigens) forming a glycocalyx-like arrangement of the epitopes inside CAP (119, 128) . As discussed below, ultrastructural studies suggest that the OL and CAP are linked to the rest of the mycobacterial wall through lipid-lipid interactions (119, 128) .
The tripartite nature of the mycobacterial cell wall
Mycobacterial cell walls have a complex tripartite structure and contain a high proportion of lipids (approximately 30% to 40% of the total weight), a significant number of which are loosely bound', i.e. extractable using organic solvents, as opposed to the 'firmly bound lipids' which can be extracted only after the saponification of the previously extracted residues. A complete description of various mycobacterial lipids can be obtained from the recent review by Asselineau and Lanéelle (6) . Most of the biologically active lipids of mycobacteria are present in the loosely bound fraction, whereas the firmly bound fraction essentially contains mycolic acid residues esterified to arabinose residues in the arabinogalactane (7) , constituting the 'cell wall skeleton' (81) . Chemical analysis of saponified and delipidated cell wall residues revealed arabinose, galactose, muramic acid, glucosamine, alanine, diaminopimelic acid and glutamic acid. In 1968, Imaeda et al. attempted to explain how the loosely-bound lipids were placed over the cell wall skeleton (74) . In the proposed model, the cell wall was assigned three distinct layers: an outer lipopolysaccharide layer (LPS), an intermediate LPS-lipid-protein complex and an inner LPS-mucopeptide layer. This model was later slightly modified by Barksdale and Kim (8) , who retained the multilayered concept with distinct L1, L2, L3 and the innermost murein layers. However, controversy remained over the existence of the mycobacterial outer layer, due to the inability to observe this layer using classical electron microscopy methods. Using ruthenium red cytochemical staining, a regularly structured outer layer of 10 nm to 12 nm (Fig. 2a) , containing acidic polysaccharides, was detected in M. avium (121) , and subsequently in all of the eighteen species of mycobacteria studied (122) . Despite being a structured monolayer, mycobacterial OL can behave as a functional bilayer by excluding some substrates and drugs (119, 126) . Specific inhibition of the surface amphiphils that form this layer, e.g. inhibition of surface glycopeptidolipids (GPLs or C-mycosides) in M. avium by m-fluorophenylalanine, resulted in OL being released into the 
Organisation of lipids in the mycobacterial cell envelope: a proposed model
During freeze-etching and freeze-fracture studies, the preferential plane of fracture passes through a plane of hydrophobic-hydrophobic interactions (e.g. both through the outer membrane and the cytoplasmic membrane [CM] in the case of Gram-negative organisms, and through the CM only in the case of Gram-positive bacteria). Among mycobacteria (17), the preferential plane of fracture passes through the cell wall rather than the CM with visible periseptal annuli and characteristic fibrillar and filamentous structures on the cell wall inner fracture face (Fig. 2d) . However, when the bacteria were treated with polymyxin-E or phenethyl alcohol (which have reversible effects on the mycobacterial CM when used at sublethal concentrations [119] ), both the inner and outer fracture faces were devoid of the characteristic fibrillar network (Fig. 2e) ; additional fractures in the CM were also observed ( Fig. 20 , with up to four additional layers in the bacterial envelope, suggesting that the mycobacterial cell envelope is organised in successive layers.
A schematised model of the mycobacterial cell envelope, based on the studies described above, is represented in Figure 2g 
Permeability barrier located in the mycobacterial cell wall
Most of the chemically-defined amphipathic substances implicated in pathogenicity, virulence. and characteristic multiple drug resistance of mycobacteria have been located in the cell wall (119, 123, 128) , which functions as an effective permeability barrier, rendering these organisms resistant to most antimicrobial agents (121, 133) . This low permeability is not solely due to the large proportions of unusual lipids in the mycobacterial cell wall, but also to the physical arrangement of these lipids. X-ray diffraction studies of purified M. chelonei cell walls confirmed the physical organisation of mycobacterial lipids, the hydrocarbon chains being predominantly arranged in a direction perpendicular to the cell surface, producing a bilayer structure (110, 111) . This highly 'organised' and 'compact' structure is responsible for the exceptionally low permeability of the mycobacterial cell wall. The role of the outer parts of the mycobacterial cell envelope, as permeability barriers, has been recently reviewed (48) . The susceptibility to drugs of the multiple drug-resistant atypical mycobacteria can be significantly enhanced by compounds known to disrupt the cell envelope (126) and diffusion of drugs through the cell envelope can be facilitated by lipophilic carriers (124, 125) . Unlike the geneticallyrelated multiple drug resistance that develops as the result of inadequate treatment of M. tuberculosis, drug resistance in atypical mycobacteria is apparently associated with the cell envelope, particularly the refractory nature of the cell envelope towards drug penetration (135) . Specific inhibition of cell envelope constituents has been successfully used to circumvent the natural resistance of these bacteria; for example, m-fluorophenylalanine, an inhibitor of GPL biosynthesis, and ethambutol, an inhibitor of arabinogalactan biosynthesis, have been reported to enhance the activity of macrolides, aminoglycosides, fluoroquinolones and rifamycins against M. avium (129, 131). Similarly, the inhibitors of glycosylation (2-deoxy-D-glucose, bacitracin and ethambutol), fatty acid biosynthesis (cerulenin) and peptide biosynthesis (N-carbamyl-L-isoleucine and m-fluorophenylalanine), which affect the biosynthesis of GPLs, led to enhanced action of macrolide, aminoglycoside and fluoroquinolone drugs against M. avium (11,134).
The above findings supported the view that exclusion might be an important mechanism of drug resistance in mycobacteria (33, 75, 121) . In fact, the interplay between cell wall barrier and β-lactamase activity was shown to determine the high resistance to β-lactam drugs in M. chelonei (76) . Although the terms permeability and exclusion have often been used interchangeably, they denote two different situations. The lipid-barrier is a non-selective exclusion barrier, whereas a permeability barrier denotes a more precise situation (e.g. that of a hydrophilic solute traversing a porin) (119) . The lipophilic pathway appears to be the major pathway in mycobacteria, as correlation between higher drug activity and increased hydrophobicity of drugs has been observed for macrolides, tetracyclines, fluoroquinolones and rifamycins (77). Conclusive evidence for lipophilic solute transport is provided by the observation that the addition of a C 16 fatty acyl chain to the otherwise hydrophilic molecule of isoniazid (which is completely inactive against M. avium), significantly increased the activity of the drug (124, 125) .
However, the penetration rate of cephalosporins across the cell wall of M. chelonei was neither strictly dependent on the hydrophobicity of the molecules, nor on the temperature. A hydrophilic pathway involving 'porins' was therefore suggested by Jarlier and Nikaido (75) . By reconstituting detergent extracts of M. chelonei cell walls into proteoliposomes, a protease-sensitive, channel-forming activity was detected, which led to the identification of a 59 kDa porin protein (178) . This minor cell wall protein of relatively lower permeability produced slightly cation-selective channels of a defined size upon reconstitution into planar bilayers, with a 2 nm channel diameter (178) . A porin with a 3 nm pore diameter and negative charges at the mouth (cation-selective) was subsequently characterised in M. smegmatis (179) . Wide pore diameters and the negatively charged channel-mouths in the two porins so far characterised tend to suggest that positively-charged hydrophilic molecules may permeate through these porins more rapidly than those which are negatively-charged. As discussed previously (110) , three distinct pathways may exist for solute penetration in mycobacteria, the lipophilic and hydrophilic pathways, and a self-promoted uptake which may involve absorption to the cell wall of a compound, leading to the subsequent disorganisation of the cell wall, thus permitting penetration. This may he the case with fairly large polycationic drugs that are active against mycobacteria (e.g. aminoglycosides). One of the pathways may be perturbed without affecting the others.
A gene coding for a porin-like protein of the ompA family from the virulent H37Rv strain of M. tuberculosis was recently studied (150) . This protein (ompATb, 38 kDa, pore diameter of approximately 1.8 nm) was identified as a porin of low specificity, and appeared to be different from mycobacterial porins previously described. Another class of porin protein (100 kDa) with a high channel-forming activity, encoded via the mspA gene was recently identified in M. smegmatis (109) .
Using Southern blotting, the authors demonstrated that several fast-growing mycobacterial species contained homologous mspA sequences in their chromosomes, whereas the slowly growing species did not appear to harbour similar sequences, suggesting that major permeability-related differences may exist between the rapidly growing mycobacterial saprophytes and slowly growing pathogenic and opportunistic mycobacteria.
Mycobacterial taxonomy
With the advent of genotyping and sequencing technologies, an improved correlation of phenotypic and genetic characteristics has permitted the redefinition of existing species, as well as the description and subsequent addition of new species. However, the naming of bacteria is controlled by the International Code of Nomenclature of Bacteria and the correct name of a bacterial taxon is based on valid publication, legitimacy, and the priority of publication. Since 1 January 1980, priority of bacterial names has been based upon the Approved Lists of Bacterial Names (155) Names not considered to be validly published should no longer be used or should be used in quotation marks (e.g. 'Bacillus mesentericus') to denote that the name is not validly published (42). According to clinical importance, mycobacteria -currently about eighty-five species (Table II) Among potential pathogens, the term M.
avium-M. intracellulare-M. scrofulaceum
(MAIS) complex was previously used to denote a group of slowly growing mycobacteria that were phenetically similar and sometimes difficult to differentiate. However, the use of the term MAIS is not encouraged, since M. scrofulaceum is now relatively easily differentiated from M. avium and M. intracellulare, using DNA-hybridisation, antigenic analysis or the ability of the organisms to hydrolyse urea. Another widely used term is 'M. avium complex' (MAC), which contains the two species M. avium and M. intracellulare, the former being composed of three distinct subspecies, namely: M. avium subsp. avium, M. avium subsp. paratuberculosis and M. avium subsp. silvaticum. Within the M. avium group, the mycobactindependence and slow growth pattern of M. paratuberculosis art remarkable (mean division time of 48 h and cultures held for sixteen weeks).
For practical purposes, mycobacteria are sometimes also differentiated into two groups known as the 'M. tuberculosis complex' (M. tuberculosis, M. africanum, M. bovis, M. microti and the newly described species M. canettx) (114) and 'mycobacteria other than the M. tuberculosis complex' (MOTT). The terms 'non-tuberculous ' or 'atypical' mycobacteria are synonymous with MOTT. Usually, though not necessarily, the strict and opportunistic mycobacterial pathogens are slow growers (a mean division time of 12 h to 24 h, with a fully-grown culture requiring approximately fifteen to twenty-eight days), except M. leprae which does not grow on artificial media, and is known to multiply every seven to fourteen days in experimental animal hosts. In contrast, most of the rare pathogens or saprophytic mycobacterial species are rapid growers (mean division time of ≤ 2 h to 6 h, with a culture available within two to seven days).
Identification based on phenotypic characteristics
Mycobacterial species are traditionally differentiated on the basis of speed of growth, optimal growth temperature, colony morphology, pigment and niacin production and serotyping. Other growth characteristics, such as the ability of some species to grow in media other than Löwenstein-Jensen, the most widely used medium for mycobacterial growth (e.g. on ordinary gelose or MacConkey broth), or the ability to grow in the presence of inhibitors such as p-nitrobenzoate and hydroxylamine, are used for species determination. In addition, specific biochemical properties are useful for discriminating among various species, for example the presence or absence of some enzymes such as urease, arylsulphatase and catalase, and/or the specific characteristics of enzymes, such as the thermoresistance of catalase.
The mycobacteria were initially divided into the M. tuberculosis complex and the non-tuberculous or atypical mycobacteria, as this discrimination could be easily performed in most microbiological laboratories. For practical purposes, Runyon proposed a classification of atypical mycobacteria in four groups (147) , based on phenotypic characteristics such as pigmentation and speed of growth. Groups I, II and III included only slowly growing mycobacteria, i.e. organisms which require more than one week to grow, whereas group IV included rapidly growing mycobacteria which require one week or less for culture. Runyon group I includes photochromogenic species, in which colonies acquire pigmentation in the presence of light only (medically important species include M. kansasii and M. marinum). Group II includes scotochromogenic species (colonies that are pigmented in the presence or absence of light), namely M. gordonae and M. scrofulaceum. Group III comprises non-chromogenic species (nonpigmented colonies) including M. avium, M. intracellulare and M. xenopi. Finally, the Runyon group IV includes rapid growers (medically important species include M. fortuitum and M. chelonae).
An updated list of the biochemical tests currently employed and the cultural properties helpful in discriminating among various species of slowly growing mycobacteria are summarised in Table III . This Table also incorporates the distribution of mycolic acid profiles upon thin layer chromatography among the species illustrated, as this remains an important chemotaxonomic marker for mycobacterial identification (35) . Results for selected rapidly growing mycobacteria are summarised in Table IV . Until the 1980s, the above phenotypic characteristics were the only tool available to classify various mycobacterial species, despite the fact that these characteristics do not allow precise identification of all the species. The results based on phenotypic characteristics may be variable at the subspecies level or may give the same results for completely different species, thus leading to false identification results in a clinical microbiology laboratory. In this context, recent molecular taxonomical approaches have provided an opportunity to improve the understanding of mycobacterial classification and phylogeny. New categories of information of potential taxonomic value have become available (e.g. chemotaxonomy, DNA base composition, DNA-DNA hybridisation) which allow very fine distinctions to be made between organisms and reveal previously undetected dissimilarities (42). New phylogenetic relationships are attracting increasing attention and have become an important basis of the taxonomy and nomenclature of actinomycetes in general, and mycobacteria in particular; for example sequences of 16S ribosomal ribonucleic acid (RNA) have provided actinomycetologists with a phylogenetic tree that allows the investigation of the evolution of actinomycetes and also provides a basis for classification (49) . Nevertheless, the distribution of some morphological and chemotaxonomic traits, such as types of peptidoglycan, menaquinone, phospholipids, cell wall sugars and fatty acids, greatly facilitates the phenotypic delineation of genera within each clade, and combinations of phenotypic properties allow the prediction of whether a new organism is likely to be a member of an established or a novel taxon (49) . However, phenotypic traits are mostly polyphyletic (with the exception of mycolic acids), and hence are an unreliable indicator of phylogenetic relationships that tend to be unpredictable and less conserved at higher taxonomic levels (e.g. at the family level) (49) . A brief discussion of the way in which the integrated use of phenotypic and genotypic characteristics is currently changing mycobacterial taxonomy is provided below.
Identification based on genotypic characteristics
For a rapid diagnosis of tuberculosis, the slow growth of the tubercle bacillus used to be a limiting factor. Because early diagnosis is highly important for the global control of tuberculosis, rapid assays based on molecular biology were developed and have been applied since the mid-1980s. The important developments that permitted a better and more rapid identification of mycobacteria are briefly reviewed below.
DNA/DNA hybridisation
The DNA/DNA hybridisation technique is a reference method for species determination which directly mirrors the homology between two entire genomes. The results are expressed as the percentage of hybridisation or as ΔTm (temperature difference between the homo-and the hetero-duplex). However, standardisation of the results and comparison between studies require the determination of ΔTm to precisely evaluate the thermal stability of hybrids obtained, which should be less than 6°C for strains belonging to the same species (159) . This value is independent of the method used and of the size of the genomes, whereas the percentage of hybridisation may vary between experiments and/or methods.
Species-specific sequences
A reliable identification may be obtained by characterising a species-specific DNA sequence by polymerase chain reaction (PCR) or hybridisation. Various PCR targets for M. tuberculosis identification include the gene encoding the MPB64 protein (98) , the gene encoding the 38 kDa protein (154) , and the mtp40 sequence (39), whereas others, such as the DT1 and DT6 sequences allow differentiation between M. intracellulare and M. avium, two MAC species (173) . Various mycobacterial species also contain a number of insertion sequences (IS) integrated in the genome. The IS belong to a number of distinct families, and studies of mycobacteria have so far revealed approximately fifty IS belonging to about ten major IS families (Table V) . A number of IS elements are present in numerous copies in mycobacterial genomes, and are species-specific, thereby increasing the sensitivity of the assays, for example IS6110 for the M. tuberculosis complex (172), IS900 for M. avium subsp. paratuberculosis (66) , and IS1245 and IS1311 J for M. avium (68, 141) .
Commercialised intragenic hybridisation probes
One of the most widely used and valuable systems exploits the polymorphisms of 16S ribosomal RNA (105) . Specific probes for M. tuberculosis, M. avium, M. intracellulare, M. kansasii and M. gordonae are commercially-available. Other systems use a PCR-based amplification of the 16S ribosomal (r)DNA, followed by hybridisation (36) . Such a system was developed to directly detect M. tuberculosis in sputum specimens (32, 43) . Polymerase chain reaction-restriction fragment length polymorphism
Other methods rely on amplification and subsequent detection of species-specific restriction fragment length polymorphisms (RFLP), for example the PCR-RFLP of hsp65 (44, 168, 169) , the internal transcribed spacer 16S-23S (ITS region [144, 145] ), or the 16S rDNA (183) . The most commonly used method involves the amplification of a 439 base-pair (bp) portion of hsp65, followed by digestion with BstEII and Haelll. The resulting data permit identification of thirty-four mycobacterial species in a single experiment (Fig. 3) .
Deoxyribonucleic acid sequencing
For taxonomical and phylogenetic studies, one of the most important targets is the gene coding for 16S rRNA (139,140). In mycobacteria,ribosomal genes are linked into an operon in the following order: 5'-m (16S rRNA) -rrl (23S rRNA) -rrf (5S rRNA) -3'. Each intergenic region inside this operon encodes for transfer RNA. This operon is present as a single copy in slowly growing mycobacteria, whereas two copies are generally present in rapidly growing species (18). The 16S rDNA gene contains two hypervariable regions (regions A and B) that contain species-specific signatures localised on a 138 bp portion of the region A and a 70 bp portion of the region B. However, a significant proportion of the species-specific variability is located within the region A, which makes this region an interesting target for mycobacterial gene sequencing studies (83, 158) . In the phylogenetic trees so far created on the basis of 16S rDNA, a distinction has been maintained between slow and rapid growers (152). By feeding all the available sequences through the GenBank (62), an updated version of a single 16S rDNA-phylogenetic tree has been created, incorporating data for slow and rapid growers (Fig. 4) . As illustrated in Figure 4 , the distinction between slow and rapid growers can be easily made on the basis of a specific signature in the 16S rDNA (a 21 bp hairpin loop in the helix 18 region for rapid growers, compared to a longer hairpin loop of 27 bp for slow growers). Nevertheless, M. simiae, M. triviale, M. intermedium, M. interjectum and M. genavense, which constitute a genetically close group, are an exception to this rule, as these species harbour a short loop ( Fig. 4; 161) .
Another interesting target is the ITS 16S-23S region, which is more variable than the 16S rDNA gene, and allows further discrimination amongst organisms at the sub-species level (e.g. the various sequevars of M. avium [41, 59, 60] and M. kansasii [11) . Sequencing of other genes, such as hsp65 (88, 138, 162, 164, 165) , dnaj (166) , sod (46) , and gyrB (84) has also been used to construct phylogenetic trees. All these genes can be considered as molecular clocks and may provide interesting and essentially compatible data on phylogeny and molecular evolution of mycobacteria. Nevertheless, uncertainties in branchings for some species or families still exist.
The hsp65 gene of M. simiae was recently compared with reported sequences of thirty-nine mycobacterial species, and a phylogenetic tree was constructed, based on the neighbourjoining method ( Fig. 5; 88 ). This tree, based on hsp65 sequences, is the first attempt in literature to group both the rapidly and slowly growing mycobacteria. With the exception of M. nonchromogenicum, this phylogenetic tree also shows distinct branches for slow growers (on the left), and the rapid growers (on the right). Among slow growers, M. simiae I, M. habana and M. simiae III form a distinct cluster, easily discriminated from related species such as M. avium, M. intracellulare, M. malmoense, M. asiaticum and M. shimoidei. Although numerical taxonomy studies generate distinct clusters corresponding to the above mentioned species, satisfactory key biochemical and/or cultural tests permitting easy differential identification of these species in clinical laboratories may sometimes be problematic, due to the variability of the test characteristics. The tree illustrated in Figure 5 also differentiated M. avium and M. avium subsp. paratuberculosis from M. intracellulare, species that share a number of common features within the broad group previously termed as the M. avium-intracellulare complex.
Mycobacteria involved in infections of animals
Mycobacterial infections of animals are of primary importance for both economic and public health reasons (91, 113 Naturally occurring mycobacterioses of animals are extremely common. In a survey of mycobacterioses among feral pigs in the Northern Territory of Australia, 47.7% of 751 feral pigs examined had macroscopic abscesses, and of these, 80.2% were suspected to be caused by mycobacteria (27) . Out of 193 pigs examined bacteriologically, a total of ninety-three •mycobacterial strains were isolated, and those typed conclusively were M. bovis (thirty-seven strains), M. avium-intracellulare complex (fifteen), M. scrofulaceum (eight), M. gordonae (two), M. simiae (two), M. szulgai (two), M. xenopi (two), M. vaccae (one) and M. kansasii (one). The authors concluded that the feral pig was probably an end host for both M. bovis and atypical mycobacteria and not a significant source of infection for cattle. Although M. bovis was not considered a significant cause of mortality in feral pigs, the authors emphasised that mycobacterioses were a significant cause of morbidity (27) . Thus, the study of potential wildlife reservoirs is of great interest and the overall epidemiology of these opportunistic pathogenic mycobacteria remains poorly understood, due to the great variety of potential environmental reservoirs.
Of the mycobacterial infections found more rarely in wild animals, one striking example concerns the naturally occurring leprosy-like infections of wild nine-banded armadillos (Dasypus novemcinctus). Although armadillos have been used since 1971 as experimental models of infection with M. leprae (a species that remains non-cultivable in vitro), several wild animals captured in 1975 were found to have a disease identical to the experimental M. leprae infection of armadillos (52). A retrospective study of sera taken from 182 armadillos between 1960 and 1964, and predating the use of these animals in leprosy research, showed that seventeen of 182 samples were positive for phenolic glycolipid-I antigen, which is specific for M. leprae (180). Therefore, M. leprae appears to be enzootic in wild armadillos. As shown previously (78), lepromatous placentitis and intrauterine foetal infections exist among pregnant lepromatous armadillos, and congenital infection is possible in leprosy of armadillos. Lepromatous armadillos have an increased susceptibility to other cultivable mycobacteria, and a number of species, including M. gordonae, M. fortuitum and M. avium, have been isolated from M. îeprae-infected animals (45) . A detailed description of M. leprae as an animal pathogen is presented in the paper by Rojas-Espinosa and Løvik in this issue (142) . 
Animal infections due to the

Mycobacterium tuberculosis complex
This topic is covered in detail in subsequent papers in this issue (29, 38, 103) , but a brief overview is presented here. The control of bovine tuberculosis in Europe was historically conducted by tuberculin-testing of cattle and slaughtering of diseased animals, and the industrial process of milk pasteurisation. In France, before milk pasteurisation, M. bovis was considered to be responsible for 10% of all cases of tuberculosis in humans. In 1937, M. bovis was isolated in 6.9% of human tuberculosis cases, whereas between 1951 and 1965, this percentage declined to 4.3%. In 1992, in England and Wales, M. bovis was estimated to represent only 1% of all mycobacterial isolates from human patients (69) . Strict regulations for cattle trade were adopted at the European Community level in 1957; to earn the cachet of 'official tuberculosis-free herd', all animals had to be free of clinical signs of tuberculosis and show negative results in two tuberculin tests which were performed by an official veterinarian at a six-month interval (24). In Canada, bovine tuberculosis in Cervidae was recognised as a potential problem in the 1990s (50) . In the USA, the eradication of bovine tuberculosis was not completed until the mid-1990s; the prevalence of herds infected with bovine tuberculosis was estimated to be 0.003%, and bovine tuberculosis still affected Puerto Rico and at least eight states of the USA in 1994 (50) . Most of the infected and exposed herds in the above case were detected during epidemiological investigations, rather than by routine testing.
Due to the economic importance of exports for the cattle industries of Australia and New Zealand, tuberculosis testing programmes were initiated rapidly and eradication programmes commenced in the dairy districts at an early stage (182) . Extended eradication programmes for cattle were launched in the 1970s, resulting in a decline in prevalence of tuberculosis-infected animals in Australia. Epidemiological evidence indicated that the Australian brushtail possum (Trichosurus vulpecula), an introduced species in New Zealand, had become a major vector of tuberculosis for cattle, and later for farmed deer (182) . Consequently, possum control, tuberculosis surveillance programmes, zoning of the country, and movement control restrictions for cattle (similar to quarantine) were introduced to solve this problem. In Latin America and the Caribbean, eleven countries, harbouring nearly 75% of the total bovine population, constitute an area of high bovine tuberculosis prevalence, and the need for improved control measures has been underlined (37) .
Wildlife reservoirs and strategies to control bovine tuberculosis
Although enhanced control efforts in many industrialised countries have led to a huge reduction in the incidence of both bovine and human tuberculosis due to M. bovis, the total eradication of bovine tuberculosis has yet not been achieved, principally because of the existence of wildlife reservoirs of infection, which vary greatly according to geographical area. Consequently, knowledge of wildlife tuberculosis may be important in the search for strategies for total elimination of animal tuberculosis (96, 97) . This could be achieved by wildlife control (82) and/or immunological approaches (107) . Wildlife control is highly dependent on knowledge of the ecology of the territories surrounding cattle production areas. This varies according to the areas studied, for example in New Zealand and Ireland, the knowledge of herd-specific risk factors is fairly comprehensive (40, 82), whereas further research is required in countries of South and Central America in which heavily infected areas still persist (37) .
Concerning the possible reservoirs of M. bovis, the Eurasian badger (Meles meles) is known to be an important susceptible host in Great Britain, whereas in New Zealand, the Australian brushtail possum is the principal source of new cases of bovine tuberculosis in cattle (82) . In Australia, marsupials have been recognised as susceptible hosts (23). In Sweden, deer herds may be subjected to M. bovis infection, and control programmes have been established (188) . In contrast, a recent study in Texas failed to identify non-bovine reservoirs of M. bovis, although the region investigated had the highest number of tuberculosis-infected catde herds of any state in the USA (115) . Between 1987 and 1997, none of the 670 mammalian, avian or environmental (soil, water and air) samples collected and cultured from the premises of the cattle herds (twelve infected and two non-infected) resulted in a positive culture for M. bovis. Furthermore, none of the. 119 human samples obtained from the employees of the dairies were positive (115) . Only 48 of 124 dairy-farm workers showed positive tuberculin skin-tests, and no difference was found in percentages of positive Tuberculin skin-test results between farms with and without a history of bovine tuberculosis within the previous two years (115). These results suggest that non-bovine reservoirs may not be Another cause for concern is tuberculosis among captive wild animals, a subject that was recently discussed by Altwood (2) . Some examples include M. bovis infection of the white-tailed deer (Odocoileus virginianus) in Michigan, USA, and the return of M. bovis to buffalo herds in the Kruger National Park (a game reserve in South Africa which covers over 20,000 km 2 and contains over 137 species of mammal). In the former case, an outbreak of M. bovis infection in wild white-tailed deer was identified in a portion of Michigan, a state bordering the Great Lakes region of the USA. Following an extensive surveillance programme, the same strain of M. bovis was isolated from multiple species, including the white-tailed deer and five carnivore species that prey on these deer. Infected animals were also diagnosed in one farmed deer herd, one dairy herd and seven beef herds.
Among potential control strategies, the vaccination of badgers was adopted in England as a means of reducing the risk of transmission to cattle (107) , and the effect of a badger control programme on the incidence of tuberculosis in a cattle population was assessed in Ireland (96) . The latter study showed that cattle herds present in the area from which badgers were removed had a significandy lower proportion of new confirmed tuberculosis cases, compared to those in areas where no systematic badger control was attempted (96) . Efficient vaccination for control of bovine tuberculosis has long been proposed, but carries the potential of compromising existing diagnostic tests. However, the understanding of protective immunity against M. bovis infection remains an important priority for bovine tuberculosis research (107) . In a recent experimental infection study in cattle, the immune responses in the peripheral blood and at the site of active disease were compared twenty weeks after infection with M. bovis, and the results obtained suggested that responses occurring in the peripheral blood may correctly reflect those at the site of the disease (136) . Another study suggested that a cocktail of antigens, rather than individual antigens, should be used for immunodiagnosis of bovine tuberculosis (137) .
infections in animals due to the Mycobacterium avium complex organisms
Mycobacterium avium complex organisms (M. avium, M. paratuberculosis and M. silvaticum) are major pathogens of animals. Mycobacterium avium, originally detected in birds, has been implicated as a pathogen of mammals, M. paratuberculosis is the aetiological agent of Johne's disease of cattle, and M. silvaticum essentially causes disease in birds (89) . Although these three organisms were initially considered as separate species within the M. avium complex, more recent numerical taxonomy studies and molecular typing approaches using DNA-DNA hybridisation, RFLP and pulsed-field gel electrophoresis, revealed that these organisms could be distinguished as three different subspecies within the single species M. avium, namely: M. avium subsp. avium, M. avium subsp. paratuberculosis and M. avium subsp. silvaticum (149, 175) . Phenotypic and genetic differences have been found to exist between the three subspecies, for example mycobactin-dependent growth and its stimulation by pyruvate on solid medium, in addition to the presence of IS900 in M. paratuberculosis, the absence of IS901 and IS902 in M. paratuberculosis (present in M. avium and M. silvaticum) and the specific presence of IS1613 in M. avium (89) . Furthermore, the three subspecies show different epidemiologies, animal hosts and reservoirs (89) . The combination of these parameters not only permits discrimination between the three subspecies, but also justifies the distinction between the three. Aspects concerning M. avium infections in birds and mammals are discussed in greater detail in the papers by Tell et al. (170) and Thorel et al. (176) in this issue.
Recendy, a significant increase in the incidence of caseous lesions in the lymph nodes of slaughter pigs prompted an extensive investigation in the Netherlands (86); of the animal groups examined (2,899 groups, 158,763 animals in total), 5% showed caseous lesions in the submaxillary and/or mesenteric lymph nodes in at least one pig. In 91.5% of the positive groups, the number of pigs affected was equal to or less than five, whereas in 8.5% of groups more than five animals were affected. Acid-fast bacteria were detected in 41% of cases by microscopic examination of Ziehl-Neelsen stained smears. Isolation and investigation of strains by IS1245-RFLP revealed that 90 of 91 isolates were M. avium, whereas one pig isolate harboured the bird-type RFLP pattern. When patterns were compared to those obtained for MAC isolates from 191 human patients, 75% similarity was detected, suggesting that pigs may be a vector of M. avium for humans, or alternatively that both pigs and humans share common environmental sources of infection (86) . Determination of confirmed epidemiological associations for MAC organisms is problematic because of the ubiquitous nature of the organisms. However, surface and drinking water, soil and foods, as well as direct contact with pet birds have been proposed as possible sources of infection. Although transmission of M. avium from poultry to humans does not appear to be a significant risk, the extensive similarities between pig and human isolates do suggest potential epidemiological links (100).
Infection by M. paratuberculosis causes Johne's disease, or paratuberculosis, a slowly developing granulomatous enteritis which is eventually fatal (174) and is responsible for important economic losses (25, 26) . All ruminant species are likely to be susceptible to infection by M. paratuberculosis, as suggested by the reports of Johne's disease in domestic agriculture (e.g. cattle, sheep and goats), free-ranging wildlife (e.g. elk, bison and Bighorn sheep) and captive wildlife (e.g. addax, springbok and oryx). Further information and references are supplied in the paper by Manning and Collins in this issue (99) . The greatest economic impact of this infection has been felt by domestic agriculture through production losses and premature culling. A discussion of Johne's disease control programmes is provided by Kennedy and Benedictus in this issue (85) .
Mycobacterium paratuberculosis
is shed by infected animals into manure, milk and colostrum; kids and calves thus acquire the organism orally. Young animals are the most susceptible, acquiring the infection directly from the dam or from a contaminated environment. The majority of strains of the organism appear to be transmitted among different species (25, 26, 174) . In Scotland, the same strain has been isolated from rabbits and their predators, foxes and stoats (lesions consistent with Johne's disease were detected), and the strain was the same as that obtained from dairy herds in the area. In a recent study, differentiation between the isolates from wild rabbits and those from cattle was not possible using molecular methods (67) . If wildlife (both ruminant and carnivorous species) serves as a reservoir for this infection, test and slaughter control programmes for domestic agriculture may not be effective and vaccination programmes may also be necessary.
Molecular tools for diagnostics and epidemiology of mycobacterial infections in animals
Spoligotyping is a recently described fingerprinting technique that allows discrimination between M. bovis isolates from cattle and human M. tuberculosis (80) . In an initial study in Spain, 182 M. bovis clinical isolates from farmed or feral animals were genotyped using this technique (3) . Results suggested that spoligotyping was useful as an initial genotyping technique, to be used prior to IS6110-RFLP. This study also showed identical spoligotypes in wild boar, deer and cattle, suggesting inter-species transmission and the existence of animal reservoirs of bovine tuberculosis in this country (3) . Using genotyping, inter-species transmission of M. bovis among wild animals (deer and badgers) and domestic livestock (cattle, sheep, goats and pigs) was suggested in Ireland (28) , and transmission between cattle and wild boar was recently suspected in northern Italy (151) .
Another study on M. bovis isolates from Australia, Canada, Ireland and Iran compared four genotyping methods, namely: IS6110-RFLP, direct repeat (DR)-RFLP, polymorphic GC-rich sequences (PGRS)-RFLP, and spoligotyping (30) . The study concluded that PGRS was the most discriminative marker (77 types identified among 273 isolates), followed by DR-RFLP and spoligotyping (35 types) and IS6110 (23 types). Another study performed on 128 M. bovis isolates from Spain proposed various typing strategies (4); given the importance of geographical variations obtained on M. bovis IS6110 copy number and insertion sites, a standardised typing procedure was proposed (31) . However, a recent study argued against the use of the standardised typing protocol using IS6110-RFLP as an initial test (191) , and suggested that the use of spoligotyping as a first-line test might easily and cost-effectively help to define primary clusters to be studied further using PGRS and 156110-typmg for confirmatory epidemiology. A recent study performed in Ireland underlined the numerous advantages of spoligotyping compared to IS6110 and confirmed the consistency of the results obtained with both techniques for epidemiological studies on M. bovis (143) . Spoligotyping has also been used to define subspecies-specific signatures within the various members of the M. tuberculosis complex. Some of these specific signatures are illustrated in Figure 6 ; for example, M. bovis shows a characteristic absence of spacers 39 to 43, whereas the recently described M. bovis subsp. caprae shows the absence of spacer 1-16.
Mycobacterial pathogenicity
The host microbicidal functions may vary depending on the location of phagocytised bacteria in different intracellular loci (93) . In all cases, by 2 h post infection, approximately 85% of the bacteria clearly resided in fused vacuoles. However, at four days post infection, fusion levels for viable H37Rv and H37Ra were reduced by half, whereas the fusion profiles of BCG and of heat-killed H37Rv and H37Ra were unchanged. A comparison of the numbers of bacteria per fused and non-fused vacuole suggested both a net transfer of bacteria out of fused vacuoles and preferential bacterial multiplication in non-fused vacuoles, and in some cases, the bacteria appeared to be free in the cytoplasm (93) . The authors concluded that viable tubercle bacilli, but neither the heat-killed bacteria nor M. bovis BCG, had the capacity to escape from fused vesicles as the infection progressed. Furthermore, after extrusion from the phagolysosomes, H37Rv, but not H37Ra, was able to multiply. Thus, virulent M. tuberculosis may elude the microbicidal mechanisms of macrophages by escaping from fused phagolysosomes into non-fused vesicles or the cytoplasm (93 ( In summary, pathogenic mycobacteria are intracellular pathogens with the ability to grow inside phagosomes and phagolysosomes, and are able to inhibit the fusion of bacteria-containing phagosomes with lysosomes upon macrophage infection (e.g. M. tuberculosis [5] , M. leprae [56] and M. avium [54, 55] ). In the case of the tubercle bacillus, this property has been attributed to bacterial sulpholipids (65) that are located on the bacterial cell surface (70) . Other important mycobacterial virulence factors include the lipoglycans (such as LAM) which are able to modulate cytokine secretion and macrophage effector functions (186) . The ability of mycobacteria to survive and modulate immune responses in the host is clearly related to the architecture of the cell envelope and the constituents contained therein (117, 132) . For example, surface products such as phenolic glycolipids, LAM and sulpholipids may also protect these organisms from intracellular killing by scavenging reactive oxygen molecules or by modulating macrophage activation (123) . The components, structure and reported biological activities of the mycobacterial wall have been reviewed in detail elsewhere (116, 118, 123) . A brief description of biological activities of selected compounds of mycobacterial origin is presented in Table VII .
Given the major differences obseived among pathogenic and non-pathogenic mycobacteria regarding the ability to trigger cytokine secretion by human macrophages (16) , it is important to identify specific cell envelope components of various pathogenic and non-pathogenic species, and characterise their ability to modulate immune responses in the infected host. A recent review discussed aspects relating to the interaction of M. tuberculosis with macrophages, and subsequent activation of tuberculocidal activity of macrophages (112) . A model has been proposed involving M. avium and a group of amphipathic substances referred to as the GPL antigens, which are one of the key elements in the cell envelope of these organisms. These serovar-specific M. avium antigens (21) localised in the exterior of the cell envelope (9, 171) tend to accumulate within the phagosomal compartments following long-term infection of macrophages (146) . Relatively inert to macrophage degradation (70, 71, 190) , the GPLs not only accumulate in host macrophages, but may persist as the infection continues. The interaction of the macrophages with biological membranes induces alterations (92) . The immunosuppressive role of M. avium lipids as a result of interaction with human monocytes (181) , and of a GPL in M. smegmatis (similar to the apolar lipids of M. avium), was demonstrated to modify membrane permeability (163) . These effects on biological membranes may be extremely important, hindering the ability of immunocompetent cells to function properly in immune reactions such as cell-to-cell recognition, phagolysosomal fusion, and electron transfers, and may be deleterious for the host. Consequendy, GPLs and related lipids may act as important immunomodulators of host responsiveness. Mycobacterium avium GPLs result in a non-specific inflammatory response when injected intraperitoneally into mice (72) . Brownback and Barrow have suggested that GPL-metabolites may also be responsible for the immunomodulatory events in the host (e.g. modification of the helper subsets of mice splenic cells) (22). Using the β-elimination procedure to remove the serovar-specific oligosaccharides from M. avium GPL (21), two major fragments are produced, namely: a residual lipid (referred to as β-lipid) and a reduced oligosaccharide (r-olig). Using mouse splenic cells, the β-lipid was demonstrated to be the active moiety with regards to the ability to suppress mitogen-induced lymphoproliferative responses (167) . In connection with these findings, the ability of total lipids and purified GPLs from M. avium serovars 4 and 8 (which predominate as opportunistic infection among AIDS patients), was demonstrated to affect T helper (TH)l-type responses in human peripheral blood mononuclear cells (PBMC) from healthy donors (73) . Exposure of PBMC to total lipids significantly suppressed phytohaemagglutinfnp/phorbol myristate acetate (PHA/PMA)-induced secretion of interleukin (IL)-2 and gamma interferon, as determined by enzyme-linked immunosorbent assay (ELISA). The GPL4 was found to be more efficient at inhibiting TH1 responses than GPL8. This study suggested that the accumulation of M. avium lipids in the chronic stages of infection may play an important role in the pathogenesis of HIV infection (73) .
Phenylalanine-containing lipopeptides from rough and smooth colony-forming M. avium serovars with immunosuppressive activity have also been identified (10) . Although the lipopeptide core has not yet been demonstrated to be a product of GPL degradation in vivo or in vitro, some of the immunosuppressive effects may be due to other lipids structurally-related to the GPL, or to metabolic products of GPL. A total lipid extract from M. avium serovar 4 not only has the capacity to reduce mitogen-induced lymphoproliferative responses of human monocytes, but may also interfere with the ability of human monocytes to control the intracellular growth of mycobacteria, probably because of the ability of the lipid extract to induce substantial prostaglandin-E2 (PGE2) secretion by cells (10) . Similar immunosuppressive properties were also observed for the β-lipid fragment of the serovar 4 GPL, but not for the r-olig or purified GPL (10) . In the case of serovar 8, both the total lipid and serovar-specific GPL fractions induced significant levels of tumour necrosis factor alpha (TNF-α) as well as PGE2 in human monocytes (12) . These findings further suggest the differing ability of mycobacterial lipids to affect immune functions. However, the role of the carbohydrate substituents of the GPL antigens versus that of the 'lipid core' should be further investigated. Rough colony variants of M. avium that do not contain the regular GPL antigens, but instead contain novel lipopeptides that are devoid of carbohydrate moieties are now available for such comparisons (15); these newly discovered lipopeptides are identical to the fatty acyl-tripeptide-amino alcohol 'core' component of the GPLs of the M. avium complex. The isolation of different sets of spontaneous mutants of M. avium that are differentially defective in the capacity to synthesise GPL antigens will permit the exploration of the biosynthesis of GPLs and their roles in opportunistic pathogenesis. Immunomodulatory properties have been demonstrated in other mycobacterial lipids, but some of these have covalent links (e.g. LAM [94] ), and hence may not be as easily released and accumulated within host macrophages as non-covalently-linked GPLs and related lipids.
The induction of cytokines by M. avium appears to be related to the colony type of the organism, which in turn is related to the difference in the cell envelope architecture (117, 118) . Thus, the more virulent smooth transparent (SmT) phenotype induces the secretion of small quantities of TNF-a, whereas the less virulent smooth dome (SmD) phenotype induces high levels of TNF-α (61) . Similarly, SmT variant of M. avium induces less secretion of IL-1 and IL-6 than the SmD phenotype (19). In this context, Belisle and Brennan have reported that the SmD morphotype always produces more GPL in total than the SmT morphotype (14) . Variability in the composition of the cell envelope is therefore likely to play an important role in the inherent ability of a particular mycobacteria to modulate immune responses in a host.
Consequently, a multiplicity of factors contribute to mycobacterial pathogenicity (133).
Concluding remarks
Since the 1980s, research into the molecular biology and genetics of mycobacteria has provided an enormous amount of information, stimulating renewed interest in medical and veterinary mycobacteriology. Molecular tools now permit a rapid diagnosis of mycobacterial infections, novel taxonomical and phylogenetic approaches, and an improved comprehension of the mechanisms of mycobacterial pathogenicity and virulence. Effective control of mycobacterial infections in animals and humans will rely heavily on knowledge of the molecular aspects underlying structure and function relationships of the mycobacterial cell envelope and the various biologically active substances and antigens contained therein, the subsequent events leading to the development of specific immunity against mycobacteria, the application of recombinant DNA technology for preparing new vaccines, and the selective production of compounds used in immunotherapy. The concerted efforts of many, as reviewed in this article, have already contributed an impressive amount of data which show promising results. However, improvements in rapid diagnostic tests and in vaccine programmes are required, particularly in terms of the organisation of field-applications, and the global co-ordination of research, diagnosis and epidemiological investigations. 
Résumé
La tuberculose, due à Mycobacterium tuberculosis, et la lèpre, due à M. leprae, sont connues depuis l'Antiquité. Dans les pays en développement, la tuberculose reste la principale cause de mortalité imputable à une maladie infectieuse. Du point de vue taxohomique, les mycobactéries appartiennent au genre Mycobacterium, genre unique de la famille des Mycobactériacées, ordre des Actinomycétales. Les Actinomycétales comprennent divers micro-organismes, mais les mycobactéries et autres taxons apparentés sont aisément reconnaissables par leur aptitude à synthétiser les acides mycoliques. Les espèces mycobactériennes se distinguent en général par leurs caractéristiques phénotypiques ; les auteurs présentent une liste actualisée des tests biochimiques utilisés ainsi que des caractères culturaux qui aident à différencier les diverses espèces de mycobactéries. Cependant, comme les caractéristiques phénotypiques ne permettent pas une identification précise de toutes les espèces, les auteurs décrivent également les méthodes récentes de taxonomie moléculaire qui permettent de classifier les mycobactéries et d'en établir la phylogénie. Les mycobactéries sont également les premières responsables d'épizooties chez plusieurs espèces d'animaux domestiques et sauvages. Les auteurs décrivent brièvement ces mycobactéries, les réservoirs existants chez les animaux sauvages et les stratégies de lutte contre la tuberculose bovine, ainsi que l'utilisation de techniques moléculaires pour le diagnostic et l'épidémiologie des infections mycobactériennes chez les animaux. Les caractéristiques du parasitisme intracellulaire font l'objet de la discussion ainsi que l'évolution des mycobactéries pathogènes qui se développent dans les phagosomes et les phagolysosomes des macrophages de l'hôte infecté. La membrane cellulaire mycobactérienne, structure tripartite complexe comportant une proportion élevée de lipides (environ 30 % à 40 % du poids total), pourrait jouer un rôle décisif dans l'adaptation des mycobactéries à la croissance et à la survie intracellulaires, ainsi que dans la modulation immunitaire et la résistance aux médicaments.
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Resumen
La tuberculosis (causada por Mycobacterium tuberculosis) y la lepra (M. leprae) son enfermedades conocidas desde la antigüedad. En países en desarrollo, la tuberculosis es todavía la primera causa de mortalidad por enfermedad infecciosa. Las micobacterias se adscriben taxonómicamente al género Mycobacterium, único de la familia Micobacteriaceae, perteneciente al orden Actinomicetales. Aunque este orden comprende microorganismos diversos, las micobacterias y taxones emparentados con ellas se distinguen fácilmente del resto por su capacidad de sintetizar ácidos micólicos. Hasta hace poco, la diferenciación entre especies micobacterianas se basaba principalmente en sus rasgos fenotípicos; los autores presentan una lista actualizada de las actuales pruebas bioquímicas y las propiedades en cultivo de las especies micobacterianas que ayudan a distinguirlas entre sí. Sin embargo, no todas las especies pueden identificarse con precisión atendiendo sólo a sus rasgos fenotípicos, y por ello los autores describen también recientes sistemas de taxonomía molecular que se aplican a la clasificación y el estudio filogenético de las micobacterias. Además de su capacidad de infectar al hombre, estos microorganismos son también una de las grandes causas de infección de diversos animales domésticos y salvajes. Los autores hacen una breve descripción de las micobacterias que infectan a los animales, sus reservorios entre la fauna salvaje, las estrategias de lucha contra la tuberculosis bovina y el uso de técnicas de biología molecular para el diagnóstico y el estudio epidemiológico de las micobacteriosis animales. Los autores examinan asimismo el característico fenómeno del parasitismo intracelular, y consideran la evolución que pueden seguir las micobacterias patógenas capaces de crecer dentro de los fagosomas y fagolisosomas de los macrófagos del huésped. La membrana celular micobacteriana, compleja estructura tripartita con una elevada proporción de lípidos (de un 30% a un 40% del peso total), podría desempeñar una función básica en la adaptación de esos microorganismos al crecimiento y la supervivencia en medio intracelular, la modulación inmunitaria y la resistencia a los antibióticos.
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